Skip to main content
The Journal of Infectious Diseases logoLink to The Journal of Infectious Diseases
. 2026 Aug 24;234(3):e751. doi: 10.1093/infdis/jiag435

Correction to: Safety, Tolerability, and Pharmacokinetics of 6-Diazo-5-Oxo-L-Norleucine in Malawian Adults With and Without Malaria: A Phase 1 Dose-Escalation Clinical Trial

PMCID: PMC13600402  PMID: 42635490

This is a correction to: Brittany A Riggle, Athanasios Chamzas, Mathangi Gopalakrishnan, Osward M Nyirenda, Nginache Nampota-Nkomba, Jane E Mallewa, Rhoda Masonga, Cynthia Manyozo, Kingsley Zuze, Alice M Liomba, Jesse Alt, Rana Rais, Barbara Slusher, Neshen Moodley, Louis H Miller, Susan K Pierce, Nicole F O’Brien, Matthew B Laurens, Douglas G Postels, Safety, Tolerability, and Pharmacokinetics of 6-Diazo-5-Oxo-L-Norleucine in Malawian Adults With and Without Malaria: A Phase 1 Dose-Escalation Clinical Trial, The Journal of Infectious Diseases, Volume 233, Issue 5, 15 May 2026, Pages e1226–e1237, https://doi.org/10.1093/infdis/jiag121

In the originally published version of this manuscript, an older version of the supplementary data file was erroneously included.

This error has been corrected.


Articles from The Journal of Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES